Helicos to Raise $18.6M from Private Financing | GenomeWeb
NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it has signed a definitive agreement with certain investors to raise gross proceeds of around $18.6 million through a private placement of the firm’s shares.
The Cambridge, Mass.-based sequencing technology firm said that net proceeds from the offering will be roughly $17.9 million, which it intends to use for working capital and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.